ION-269 / Ionis - LARVOL DELTA

Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD) (clinicaltrials.gov) - P1 | N=1 | Active, not recruiting | Sponsor: Ionis Pharmaceuticals, Inc. | Recruiting ➔ Active, not recruiting | N=30 ➔ 1

Enrollment change • Enrollment closed • Alzheimer's Disease • CNS Disorders • Developmental Disorders • Genetic Disorders